Frontiers | Studying Huntington's Disease in Yeast: From Mechanisms to Pharmacological Approaches
Hippocampal alterations of Pyk2 and synaptic markers in Huntington's... | Download Scientific Diagram
Frontiers | The Role of DNA Damage in Neural Plasticity in Physiology and Neurodegeneration
IJMS | Free Full-Text | Structural Plasticity of the Hippocampus in Neurodegenerative Diseases
Epigenetic Mechanisms of Neural Plasticity in Chronic Neuropathic Pain | ACS Chemical Neuroscience
mGluR5 antagonism increases autophagy and prevents disease progression in the zQ175 mouse model of Huntington's disease | Science Signaling
The neuroplasticity marker PSA-NCAM: Insights into new therapeutic avenues for promoting neuroregeneration - ScienceDirect
Frontiers | Reactive Neuroblastosis in Huntington's Disease: A Putative Therapeutic Target for Striatal Regeneration in the Adult Brain
Increasing brain palmitoylation rescues behavior and neuropathology in Huntington disease mice | Science Advances
Frontiers | Quantification of Huntington's Disease Related Markers in the R6/2 Mouse Model
Frontiers | Quantification of Huntington's Disease Related Markers in the R6/2 Mouse Model
Transplantation of Induced Pluripotent Stem Cells Improves Functional Recovery in Huntington's Disease Rat Model | PLOS ONE
Distinct regulation of hippocampal neuroplasticity and ciliary genes by corticosteroid receptors | Nature Communications
Huntington's disease brain-derived small RNAs recapitulate associated neuropathology in mice | SpringerLink
Neuroplasticity and epigenetic markers in exercised mice compared to... | Download Scientific Diagram
Neuroplasticity – HOPES Huntington's Disease Information
Pyk2 modulates hippocampal excitatory synapses and contributes to cognitive deficits in a Huntington's disease model | Nature Communications
Increasing brain palmitoylation rescues behavior and neuropathology in Huntington disease mice | Science Advances
Relationship between different biological and bioimaging markers of... | Download Scientific Diagram
Synapsin-caveolin-1 gene therapy preserves neuronal and synaptic morphology and prevents neurodegeneration in a mouse model of AD - ScienceDirect
The Emerging Landscape of Small-Molecule Therapeutics for the Treatment of Huntington's Disease | Journal of Medicinal Chemistry
Pyroptotic cell death in the R6/2 mouse model of Huntington's disease: new insight on the inflammasome | Cell Death Discovery
Frontiers | Quantification of Huntington's Disease Related Markers in the R6/2 Mouse Model
Human Mesenchymal Stem Cells Prolong Survival and Ameliorate Motor Deficit through Trophic Support in Huntington's Disease Mouse Models | PLOS ONE
